Adial Pharmaceuticals ADIL
NASDAQ ADIL
$4.26 +0.44 (+11.65%)
As of: Oct 21, 2026 · 3:45 PM EDT

Adial Pharmaceuticals (ADIL) Share-based Compensation (IS) (2017 - 2018)

Updated

Adial Pharmaceuticals' Share-based Compensation (IS) was $31,473 in Q3 2018, down 51.7% from $65,129 a year earlier.

Analysis

Adial Pharmaceuticals (ADIL) Share-based Compensation (IS) (2017 - 2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Adial Pharmaceuticals 19.71 Mn -24.07 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2018 31,473.00
Sep 30, 2017 65,129.00
API Access

Adial Pharmaceuticals Share-based Compensation (IS) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=ADIL&period=max&api_key=YOUR_API_KEY